Atox BIO Ltd — Federal Contractor Profile

Contractor Overview

Total Contract Value: $36,636,289 ($36.6M)

Total Awards: 2

Company Profile

ATOX BIO LTD is a federal contractor with a total government contract value of $36.6 million, spanning two contracts with an average size of $18,318,145. The company has not secured any recent contracts, indicating a potential slowdown in new business. ATOX BIO LTD has not engaged in any sole-source contracts, suggesting a preference for competitive bidding. However, the lack of recent contracts and the absence of specific agency clients makes it challenging to assess their relationship with government agencies. The company's core capabilities and specializations are not clearly defined from the available data, and there is no information on notable projects or performance history. Given the limited data, it is difficult to draw conclusions about their business strategy or market position. ATOX BIO LTD's contract patterns suggest a need for further investigation to understand their role in government spending and their value to taxpayers.

Specializations

• Biotechnology
• Biological Research
• Contract Research Organization (CRO)
• Pharmaceutical Development
• Clinical Trials

Contractor Metrics

Average Contract Size: $0

Competitive Win Rate: 100%

Agency Concentration: N/A

Growth Trajectory: Stable

Sole Source Rate: 0%

Recompete Rate: N/A

Competitive Position

ATOX BIO LTD's lack of recent contracts and absence of specific agency clients make it challenging to assess their market position. However, their preference for competitive bidding suggests they are likely a niche player in the biotechnology and pharmaceutical development sectors, competing against other specialized firms. Their focus on research and development indicates they may hold a specialized niche in the industry.

Value to Taxpayers

Given the limited data, it is difficult to assess whether ATOX BIO LTD provides good value for taxpayer money. Their average contract size of $18,318,145 suggests significant investment, but without specific project details or performance metrics, it is hard to determine if the value provided justifies the cost. The company's preference for competitive bidding indicates they are likely transparent and fair in their contract acquisition process.

Agency Relationships

The lack of specific agency clients and recent contracts makes it challenging to assess ATOX BIO LTD's relationship with government agencies. However, their absence from recent contract activity may indicate a potential risk of dependency on a few key agencies. Without a diversified client base, the company may face challenges if their primary clients reduce their spending or shift to other contractors.

Red Flags

• No recent contracts: This could indicate a slowdown in new business or potential financial instability.
• Lack of specific agency clients: This may suggest a lack of established relationships with key government agencies.
• No competitive or sole-source patterns: The absence of any contract patterns makes it difficult to assess their business strategy.

Green Flags

• Preference for competitive bidding: This suggests transparency and fairness in contract acquisition.
• No sole-source contracts: This indicates a commitment to competitive processes.
• No recent contracts: While concerning, it could also indicate a strategic pause in contract acquisition.

Key Contracts

ATOX BIO LTD has secured two contracts with a total value of $36.6 million. The lack of specific details on these contracts makes it challenging to assess their capabilities and performance. However, the absence of recent contracts and the absence of any notable projects or performance history suggests that the company may be in a period of transition or may be focusing on internal development. Their preference for competitive bidding indicates a commitment to fair and transparent processes, which is a positive aspect of their business strategy.

Frequently Asked Questions

What does ATOX BIO LTD do for the federal government?

ATOX BIO LTD is a federal contractor specializing in biotechnology, biological research, and pharmaceutical development. They likely provide services such as contract research organization (CRO) activities, clinical trials, and pharmaceutical development. Their core capabilities include research and development in biotechnology and pharmaceuticals, supporting government agencies in various scientific and medical initiatives.

How much taxpayer money does ATOX BIO LTD receive?

ATOX BIO LTD has secured a total of $36.6 million in federal contracts, with an average contract size of $18,318,145. This indicates significant investment from the government, but without specific project details, it is difficult to assess the exact nature and scope of the work they perform. The company has not secured any recent contracts, suggesting a potential slowdown in new business.

Is ATOX BIO LTD good value for taxpayer money?

Given the limited data, it is difficult to assess whether ATOX BIO LTD provides good value for taxpayer money. Their average contract size of $18,318,145 suggests significant investment, but without specific project details or performance metrics, it is hard to determine if the value provided justifies the cost. The company's preference for competitive bidding indicates they are likely transparent and fair in their contract acquisition process.

How does ATOX BIO LTD win its contracts?

ATOX BIO LTD has not engaged in any sole-source contracts, indicating a preference for competitive bidding. This suggests that the company competes against other specialized firms in the biotechnology and pharmaceutical development sectors. Their focus on research and development indicates they may hold a specialized niche in the industry, competing based on their expertise and capabilities.

What agencies use ATOX BIO LTD most?

The lack of specific agency clients and recent contracts makes it challenging to assess which agencies rely most on ATOX BIO LTD. However, their absence from recent contract activity may indicate a potential risk of dependency on a few key agencies. Without a diversified client base, the company may face challenges if their primary clients reduce their spending or shift to other contractors.

What are the risks of relying on ATOX BIO LTD?

The lack of recent contracts and the absence of specific agency clients make it challenging to assess the risks of relying on ATOX BIO LTD. However, their absence from recent contract activity may indicate a potential risk of dependency on a few key agencies. Without a diversified client base, the company may face challenges if their primary clients reduce their spending or shift to other contractors. Additionally, the absence of any notable projects or performance history suggests that the company may be in a period of transition or may be focusing on internal development.

How does ATOX BIO LTD compare to similar contractors?

ATOX BIO LTD's lack of recent contracts and absence of specific agency clients make it challenging to compare them to similar contractors. However, their preference for competitive bidding suggests they are likely a niche player in the biotechnology and pharmaceutical development sectors, competing against other specialized firms. Their focus on research and development indicates they may hold a specialized niche in the industry, competing based on their expertise and capabilities. Without specific data on their competitors, it is difficult to provide a comprehensive comparison.

Recent Federal Contracts

Atox BIO Ltd has 1 federal contracts on record. Below are the largest awards:

Related Pages